MATURE OOCYTE YIELDS IN LOW PROGNOSIS PATIENTS USING LUTEAL PHASE ESTROGEN WITH AND WITHOUT GNRH ANTAGONIST

Previous
Previous

A foundational model for in vitro fertilization trained on 18 million time-lapse images

Next
Next

BEYOND NUMBERS: UNRAVELING THE COMPLEX RELATIONSHIP BETWEEN AMH AND AFC LEVELS AND EMBRYO QUALITY